Privia Health Group/$PRVA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Privia Health Group
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Ticker
$PRVA
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
1,140
ISIN
US74276R1023
Website
PRVA Metrics
BasicAdvanced
$2.6B
175.90
$0.12
0.87
-
Price and volume
Market cap
$2.6B
Beta
0.87
52-week high
$26.09
52-week low
$16.47
Average daily volume
971K
Financial strength
Current ratio
1.883
Quick ratio
1.823
Long term debt to equity
0.43
Total debt to equity
0.766
Profitability
EBITDA (TTM)
28.725
Gross margin (TTM)
10.09%
Net profit margin (TTM)
0.87%
Operating margin (TTM)
1.19%
Effective tax rate (TTM)
37.81%
Revenue per employee (TTM)
$1,580,000
Management effectiveness
Return on assets (TTM)
1.21%
Return on equity (TTM)
3.01%
Valuation
Price to earnings (TTM)
175.899
Price to revenue (TTM)
1.405
Price to book
3.88
Price to tangible book (TTM)
6.25
Price to free cash flow (TTM)
21.381
Free cash flow yield (TTM)
4.68%
Free cash flow per share (TTM)
98.69%
Growth
Revenue change (TTM)
6.79%
Earnings per share change (TTM)
-20.04%
3-year revenue growth (CAGR)
19.09%
3-year earnings per share growth (CAGR)
-60.81%
What the Analysts think about PRVA
Analyst ratings (Buy, Hold, Sell) for Privia Health Group stock.
Bulls say / Bears say
Privia Health reported strong Q1 2025 financial results, with total revenue increasing by 15.6% to $480.1 million and operating income surging by 534% to $5.2 million, indicating robust operational performance. (stocktitan.net)
The company expanded into Arizona by partnering with Integrated Medical Services, adding approximately 70 healthcare providers and marking its entry into its 15th state, which could drive future growth. (stocktitan.net)
Analyst coverage has been positive, with Needham initiating a 'Buy' recommendation for Privia Health, suggesting confidence in the company's growth prospects. (nasdaq.com)
Despite strong Q4 2024 sales, Privia Health's full-year 2025 revenue guidance of $1.85 billion at the midpoint came in 2.2% below analysts' estimates, potentially indicating future revenue challenges. (stockstory.com)
Insiders at Privia Health sold approximately $898,000 worth of stock, which could signal potential concerns about the company's future performance. (simplywall.st)
The healthcare industry faces ongoing regulatory challenges and reimbursement pressures, which could impact Privia Health's profitability and growth. (businesswire.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.
PRVA Financial Performance
Revenues and expenses
PRVA Earnings Performance
Company profitability
PRVA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Privia Health Group stock?
Privia Health Group (PRVA) has a market cap of $2.6B as of July 11, 2025.
What is the P/E ratio for Privia Health Group stock?
The price to earnings (P/E) ratio for Privia Health Group (PRVA) stock is 175.9 as of July 11, 2025.
Does Privia Health Group stock pay dividends?
No, Privia Health Group (PRVA) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Privia Health Group dividend payment date?
Privia Health Group (PRVA) stock does not pay dividends to its shareholders.
What is the beta indicator for Privia Health Group?
Privia Health Group (PRVA) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.